TrialBMC cancer2017

Randomized study comparing full dose monotherapy (S-1 followed by irinotecan) and reduced dose combination therapy (S-1/oxaliplatin followed by S-1/irinotecan) as initial therapy for older patients with metastatic colorectal cancer: NORDIC 9.

Stine Braendegaard Winther et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.